The Role of Angiopoietin-Like Proteins in Angiogenesis and Metabolism

Trends in Cardiovascular Medicine

Volumn 18, Issue 1, 2008, Pages 6-14

  Hato, Tai ^a   Tabata, Mitsuhisa ^a,b   Oike, Yuichi ^a,b,c  

^a KEIO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN; GLUCOSE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARCINOGENESIS; GLUCOSE METABOLISM; HUMAN; METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANGIOPOIETINS; ANIMALS; ENERGY METABOLISM; FISHES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 38149050613     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.10.003     Document Type: Review

References (86)

1. Akiyama T.E., Lambert G., Nicol C.J., et al. Peroxidase proliferator-activated receptor β/δ regulates very low density lipoprotein production and catabolism in mice on a western diet. J Biol Chem 279 (2004) 20874-20881
2. Ando Y., Shimizugawa T., Takeshita S., et al. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J Lipid Res 44 (2003) 1216-1223
3. Asia Pacific Cohort Studies Collaboration. The burden of overweight and obesity in the Asia-Pacific region. Obes Rev 8 (2007) 191-196
4. Bäckhed F., Crawford P.A., O'Donnell D., et al. Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc Natl Acad Sci U S A 104 (2007) 606-611
5. Bäckhed F., Manchester J., Semenkovich C.F., et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104 (2007) 979-984
6. Bäckhed F., Ding H., Way T., et al. The gut microbiota as an environmental factor that regulate fat storage. Proc Natl Acad Sci U S A 101 (2004) 15718-15723
7. Bourcier M.N., Sukhova G.K., Libby P., et al. PPAR gamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPAR gamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 19 (1999) 546-551
8. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40 (2004) 1387-1395
9. Burkhard P., Stetefeld J., and Strelkov SV. Coiled coils: a highly versatile protein folding motif. Trends Cell Biol 11 (2001) 82-88
10. Camenisch G., Pisabarro M.T., Sherman D., et al. ANGPLT3 stimulates endothelial cell adhesion and migration via integrin αvβ3 and induces blood vessel formation in vivo. J Biol Chem 277 (2002) 17281-17290
11. Carlson T.R., Feng Y., Maisonpierre P.C., et al. Direct cell adhesion to the angiopoietins mediated by integrins. J of Biol Chem 276 (2001) 26516-26525
12. Cazes A., Galaup A., Chomel C., et al. Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 99 (2006) 1207-1215
13. Cho C.H., Kammerer R.A., Lee H.J., et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 101 (2004) 5547-5552
14. Davis S., Papadopoulos N., Aldrich T.H., et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10 (2003) 38-44
15. De Gooyer T.E., Stevenson K.A., Humphries P., et al. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci 47 (2006) 5561-5568
16. Delahay R., and Frankel G. Coiled-coil proteins associated with type III secretion systems: a versatile domain revisited. Mol Microbiol 45 (2002) 905-916
17. Desai U., Lee E.C., Chung K., et al. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci U S A 104 (2007) 11766-11771
18. Dhanabal M., LaRochelle W.J., Jeffers M., et al. Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. Cancer Res 62 (2002) 3834-3841
19. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat Med 4 (2004) 355-361
20. Fugier C., Tousaint J.J., Prieur X., et al. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone. J Biol Chem 281 (2006) 11553-11559
21. Fujimoto K., Koishi R., Shimizugawa T., et al. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim 55 (2006) 27-34
22. Garinano RF, Gardner TW: 2005. Retinal angiogenesis in development and disease. Nature. 438:960-966.
23. Ge H., Yang G., and Huang L. Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4. J Biol Chem 279 (2004) 2038-2045
24. Ge H., Yang G., Yu X., et al. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J Lipid Res 45 (2004) 2071-2079
25. Ge H., Cha J.Y., Gopal H., et al. Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res 46 (2005) 1484-1490
26. Gordan J.D., Thompson C.B., and Simon M.C. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12 (2007) 108-113
27. Hatsuda S., Shoji T., Shinohara K., et al. Association between angiopoietin-like 3 and arterial wall thickness in healthy subjects. J Vasc Res 44 (2007) 61-66
28. Hickey M.M., and Simon M.C. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 76 (2006) 217-257
29. Inaba T., Matsuda M., Shimamura M., et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J Biol Chem 278 (2003) 21344-21351
30. Inukai K., Nakashima Y., Watanabe M., et al. ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem Biophys Res Commun 317 (2004) 1075-1079
31. Ito Y., Oike Y., Yasunaga K., et al. Inhibition of angiogenesis and vascular leakiness by angiopoietin related protein 4. Cancer Res 63 (2003) 6651-6657
32. Jin W., Wang X., Millar J.S., et al. Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 6 (2007) 129-136
33. Kaplan R., Zang T., Hernandez M., et al. Regulation of the angiopoietin-like protein 3 gene by LXR. J Lipid Res 44 (2003) 136-143
34. Katoh Y., and Kato M. Comparative intergenomics on angiopoietin family members. Int J Mol Med 17 (2006) 1145-1149
35. Keevil J.G., Cullen M.W., Gangnon R., et al. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002. Circulation 115 (2007) 1363-1370
36. Kersten S. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 33 (2005) 1059-1062
37. Kersten S., Mandard S., Tan N.S., et al. Characterization of the fasting induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275 (2000) 28488-28493
38. Kim I., Kwak H.J., Ahn H.J., et al. Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett 443 (1999) 353-356
39. Kim I., Moon S.O., Koh K.N., et al. Molecular cloning, expression, and characterization of angiopoietin-related protein. J Biol Chem 274 (1999) 26523-26528
40. Kim I., Kim H.G., Kim H., et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J 346 (2000) 603-610
41. Kitazawa M., Ohizumi Y., Oike Y., et al. Angiopoietin-related growth factor (AGF) suppresses gluconeogenesis through the Akt/FoxO1-dependent pathway in hepatocytes. J Pharmacol Exp Ther (2007) 17804676 epub ahead of print
42. Koishi R., Ando Y., Ono M., et al. Angptl3 regulates lipid metabolism in mice. Nat Genet 30 (2002) 151-157
43. Korstanje R., Eriksson P., Samnegard A., et al. Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis 177 (2004) 443-450
44. Koster A., Chao Y.B., Mosior M., et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 146 (2005) 4943-4950
45. Kubota Y., Oike Y., Satoh S., et al. Cooperative interaction of angiopoietin-like proteins 1 and 2 in zebrafish vascular development. Proc Natl Acadof Sci U S A 102 (2005) 13502-13507
46. Kubota Y., Oike Y., Satoh S., et al. Isolation and expression patterns of genes for three angiopoietin-like proteins, Angitp1, 2, and 6 in zebrafish. Gene Expr Patterns 5 (2005) 679-685
47. Lai D., Tu Y., Hsieh Y., et al. Angiopoietin-like protein 1 expression is related to intermuscular connective tissue and cartilage development. Dev Dyn 236 (2007) 2643-2652
48. Lefebvre P., Chinetti G., Fruchart J.C., et al. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116 (2006) 571-580
49. Le Jan S., Amy C., Cazes A., et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 162 (2003) 1521-1528
50. Liao D., and Johnson R.S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26 (2007) 281-290
51. Lichtenstein L., Berbee J.F., Van Dijk S.J., et al. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol (2007) 10.1161, published online
52. Mandard S., Zandbergen F., Tan N.S., et al. The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 279 (2004) 34411-34420
53. Mandard S., Zandbergen F., Van Straten E., et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281 (2006) 934-944
54. McTigue K., Larson J.C., Valoski A., et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 296 (2006) 79-86
55. Oike Y., Yasunaga K., Ito Y., et al. Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling and regeneration. Proc Natl Acad Sci U S A 100 (2003) 9494-9499
56. Oike Y., Ito Y., Maekawa H., et al. Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 103 (2004) 3760-3766
57. Oike Y., and Yasunaga K. Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int J Hematol 80 (2004) 21-28
58. Oike Y., Akao M., Yasuanga K., et al. Angiopoietin-like proteins: potential new targets for therapy of metabolic syndrome. Trends Mol Med 11 (2005) 473-479
59. Oike Y., Akao M., Suda T., et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med 11 (2005) 400-408
60. Ono M., Shimizugawa T., Shimamura M., et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 278 (2003) 41804-41809
61. Peng X.H., Karna P., Cao Z., et al. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 281 (2006) 25903-25914
62. Procopio W.N., Pelavin P.I., Lee W.M., et al. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem 274 (1999) 196-201
63. Rak J., and Yu J.L. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand". Semin Cancer Biol 14 (2004) 93-104
64. Romeo S., Pennacchio L.A., Boerwinkle E., et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39 (2007) 513-516
65. Schnohr P., Jensen G., Scharling H., et al. The Copenhagen City Heart Study. Osterbroundersogelsen. Tables with data from the third examination. 1991-1994. Eur Heart J 3 suppl (2001) H1-H83
66. Shimamura M., Matsuda M., Ando Y., et al. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem Biophys Res Commun 322 (2004) 1080-1085
67. Shimamura M., Matsuda M., Kobayashi S., et al. Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res Commun 301 (2003) 604-609
68. Shimamura M., Matsuda M., Yasumo H., et al. Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 27 (2007) 366-372
69. Shimizugawa T., Ono M., Shimamura M., et al. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 277 (2002) 33742-33748
70. Stzamari I., Torocsik D., Agostini M., et al. PPAR{gamma} regulates the function of human dendritic cells primarily by altering lipid metabolism. Blood 110 (2007) 3271-3280
71. Sukonina V., Lookene A., Olivercrona T., et al. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci U S A 103 (2006) 17450-17455
72. The ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 129 (1989) 687-702
73. Varet J., Vincent L., Mirshahi P., et al. Fenofibrate inhibits angiogenesis in vitro and in vivo. Cell Mol Life Sci 60 (2003) 810-819
74. Victor R.G., Haley R.W., Willett D.L., et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93 (2004) 1473-1480
75. Walczack R., Josheph S.B., Laffitte B.A., et al. Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors. J Biol Chem 279 (2004) 9905-9911
76. Wang Y., Lam K.S., Lam J.B., et al. Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in liver tissues of db/db diabetic mice. Mol Endocrinol 21 (2007) 972-986
77. Wigle J.T., and Oliver G. Prox-1 function is required for the development of murine lymphatic system. Cell 98 (1999) 769-778
78. Wyatt S.B., Winters K.P., and Dubbert P.M. Overweight and obesity: prevalence, consequences, and causes of a growing publish health problem. Am J Med Sci 331 (2006) 166-174
79. Xin X., Yang S., Kowalski J., et al. Peroxisome proliferator-activated receptor gamma ligands are potent target of angiogenesis in vitro and in vivo. J Biol Chem 13 (1999) 9116-9119
80. Xu A., Lam M.C., Chan K.W., et al. Angiopoietin-like protein 4 decrease blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A 102 (2005) 6086-6091
81. Yach D., Stuckler D., and Brownell K.D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12 (2006) 62-66
82. Yoon J.C., Chickering T.W., Rosen E.D., et al. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. Mol Cell Biol 20 (2000) 5343-5349
83. Yoshida K., Shimizugawa T., Ono M., et al. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43 (2002) 1770-1772
84. Zang C.C., Kaba M., Lodish H.F., et al. Angiopoietin-like proteins stimulate ex vivo expansion of haematopoietic stem cells. Nat Med 12 (2006) 240-245
85. Zandbergen F., Van Dijk S., Muller M., et al. Fasting-induced adipose factor/angiopoietin-like protein 4: a potential target for dyslipidemia?. Future Lipidol 1 (2006) 227-236
86. Zeng L., Dai J., Ying K., et al. Identification of novel human angiopoietin-like gene expressed mainly in heart. J Hum Genetics 48 (2003) 159-162